Home > Insider Trading > Filing (0001562180-22-005708)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1822791	Clene Inc.	CLNN	Pharmaceutical Preparations (2834)	852828339

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1835330	Dee Robert Etherington	6550 South Millrock Drive Suite G50 Salt Lake City UT 84121	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-07-18	23,483	$4.72	56,593	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	12,717	Indirect	By LLC

Footnotes

The sales reported in this Form 4 represent shares of common stock of Clene Inc. required to be sold by Mr. Etherington to satisfy tax obligations in connection with the vesting of 80,076 restricted stock awards. The sales occurred automatically to satisfy tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan at a weighted average price of $4.72; the shares were sold in multiple transactions at prices ranging from $4.36 to $4.94, inclusive.
The securities are owned by RDE RX Ventures LLC. Mr. Etherington is the manager of RDE RX Ventures LLC. The shares owned by RDE RX Ventures LLC may also be deemed to be beneficially owned by Mr. Etherington.